Announce Date | 05/06/2025 |
EPS Normalized Actual | $0.01 (Beat by $0.02) |
EPS GAAP Actual | $0.01 (Beat by $0.02) |
Revenue Actual | $0B |
Revenue Surprise | Beat by $0M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $-0.12 |
EPS GAAP Estimate | $-0.12 |
Revenue Estimate | $0.0168B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 0.05 | 89.4 | 0.04958867 | 0.05041133 | 0 |
Dec 2026 | -0.04 | -111.75 | -0.04032906 | -0.03967094 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0 | 0.025 | 0B | -INF% | -16.24M |
FQ3 2024 (Sep 2024) | 0.13 | -1.41141 | -0.024396B | 164.07% | -56.11M |
FQ2 2024 (Jun 2024) | -0.0379 | -0.0379 | 0.012395B | -13.73% | 12.4M |
FQ1 2019 (Mar 2019) | -0.64 | -0.64 | 0.002973B | 100% | 2.97M |
FQ2 2019 (Jun 2019) | -0.66 | -0.66 | 0.003572B | 100% | 3.57M |
FQ3 2019 (Sep 2019) | -0.69 | -0.69 | 0.004791B | 100% | 4.79M |
FQ4 2019 (Dec 2019) | -0.5 | -0.5 | 0.00669B | 100% | 6.69M |
FQ1 2024 (Mar 2024) | -0.0945 | -0.0945 | 0.012001B | -3.22% | 12M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
-0.12
Consensus Revenue Estimates
0.0168B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Oct 2026) | 0.03 | -- | 0.02961446 | 0.03039906 | 0 |
FQ3 2026 (Jul 2026) | -0.01 | -- | -0.01013302 | -0.00987149 | 0 |
FQ2 2026 (Jun 2026) | 0 | -- | 0 | 0 | 0 |
FQ1 2026 (Mar 2026) | -0.01 | -- | -0.01019883 | -0.00980117 | 0 |
FQ4 2025 (Oct 2025) | 0.01 | -- | 0.00987149 | 0.01013302 | 0 |
FQ3 2025 (Jul 2025) | -0.03 | 533.33 | -0.03039906 | -0.02961446 | 0 |
FQ2 2025 (Jun 2025) | -0.12 | 68.42 | -0.12 | -0.12 | 0 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Oct 2026) | 0.02B | -- | 0.02B | 0.02B | 0 |
FQ3 2026 (Jul 2026) | 0.02B | -- | 0.02B | 0.02B | 0 |
FQ2 2026 (Jun 2026) | 0.02B | -- | 0.02B | 0.02B | 0 |
FQ1 2026 (Mar 2026) | 0.02B | -- | 0.02B | 0.02B | 0 |
FQ4 2025 (Oct 2025) | 0.02B | -- | 0.02B | 0.02B | 0 |
FQ3 2025 (Jul 2025) | 0.01B | 278.07 | 0.01B | 0.01B | 0 |
FQ2 2025 (Jun 2025) | 0.02B | 26.22 | 0.02B | 0.02B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
7
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | -0.025 | 0 | 0.025 | INF% |
FQ3 2024 (Sep 2024) | 1.54141 | 0.13 | -1.41141 | -1085.7% |
FQ2 2024 (Jun 2024) | -0.0379 | -0.0379 | 100% | |
FQ1 2019 (Mar 2019) | -0.64 | -0.64 | 100% | |
FQ2 2019 (Jun 2019) | -0.66 | -0.66 | 100% | |
FQ3 2019 (Sep 2019) | -0.69 | -0.69 | 100% | |
FQ4 2019 (Dec 2019) | -0.5 | -0.5 | 100% | |
FQ1 2024 (Mar 2024) | -0.0945 | -0.0945 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0.02B | $0B | $-16.24M | -INF% |
FQ3 2024 (Sep 2024) | $0.03B | $-0.02B | $-56.11M | 230.01% |
FQ2 2024 (Jun 2024) | $0B | $0.01B | $12.4M | 100% |
FQ1 2019 (Mar 2019) | $0B | $0B | $2.97M | 100% |
FQ2 2019 (Jun 2019) | $0B | $0B | $3.57M | 100% |
FQ3 2019 (Sep 2019) | $0B | $0B | $4.79M | 100% |
FQ4 2019 (Dec 2019) | $0B | $0.01B | $6.69M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.01B | $12M | 100% |